F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$90.56M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.48M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+43.74%

Volume	10,924
Open	37.65
Previous Close	37.91
Day's Range	37.63 - 37.79
52-Week Low	18.78
52-Week High	37.99
Beta	n/a
Holdings	38
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

51.03% of assets

Name	Symbol	Weight
Cogent Biosciences, Inc.	COGT	10.04%
LivaNova PLC	LIVN	6.61%
Travere Therapeutics, Inc.	TVTX	5.26%
Guardant Health, Inc.	GH	5.22%
TransMedics Group, Inc.	TMDX	5.11%
Madrigal Pharmaceuticals, Inc.	MDGL	4.24%
BridgeBio Pharma, Inc.	BBIO	4.12%
Savara Inc.	SVRA	3.88%
Corcept Therapeutics Incorporated	CORT	3.40%
KalVista Pharmaceuticals, Inc.	KALV	3.15%